GlassScriptPhysician profile
Hsiao L Lai
NPI 1285841379
$1,486.94
in general payments reported to CMS, 2019-2025
17 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $163 · 2021: $169 · 2022: $254 · 2023: $308 · 2024: $156 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Education: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.96 |
| Education | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $235.30 | 2020-2023 | Veltassa |
| Alexion Pharmaceuticals, INC. | $194.80 | 2019-2023 | Ultomiris |
| Recor Medical INC | $184.32 | 2025 | Paradise Ultrasound Renal Denervation System |
| Aurinia Pharma U.S., INC. | $135.61 | 2021-2024 | Lupkynis |
| Bayer Healthcare Pharmaceuticals INC. | $123.91 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $113.95 | 2020-2024 | Acthar, Terlivaz |
| Amgen INC. | $80.58 | 2021-2024 | Tavneos |
| Astrazeneca Pharmaceuticals LP | $74.85 | 2020-2023 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $57.49 | 2019-2020 | |
| Calliditas Therapeutics US INC. | $56.32 | 2022 | |
| Mallinckrodt Enterprises LLC | $50.38 | 2019 | |
| Travere Therapeutics, INC. | $45.31 | 2023-2025 | Filspari |
| Akebia Therapeutics INC | $40.61 | 2020-2023 | Auryxia |
| Genzyme Corporation | $39.00 | 2019-2022 | |
| Horizon Therapeutics Plc | $19.55 | 2023 | Krystexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $18.31 | 2020 | |
| Shire North American Group INC | $16.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsiao Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.